FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA notes a supplemental application for Tafluprost Ophthalmic (TAFLUPROST) submitted by Prasco Laboratories. The document indicates the status of the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TAFLUPROST OPHTHALMIC (TAFLUPROST)

Snippet

SUPPL AP for TAFLUPROST OPHTHALMIC (TAFLUPROST)